Harmony Biosciences Holdings, Inc. (HRMY)
36.13
+0.10
(+0.28%)
USD |
NASDAQ |
Oct 23, 16:00
36.07
-0.06
(-0.17%)
After-Hours: 20:00
Harmony Biosciences Holdings Price : 36.13 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 36.11 | 37.05 | 35.00 | 36.13 | 2.314M |
| Oct 22, 2026 | 38.50 | 39.64 | 34.11 | 36.03 | 2.906M |
| Oct 21, 2026 | 38.58 | 38.93 | 38.13 | 38.31 | 1.063M |
| Oct 20, 2026 | 37.99 | 39.23 | 37.49 | 38.70 | 798586.0 |
| Oct 19, 2026 | 37.84 | 37.97 | 37.16 | 37.54 | 1.008M |
| Oct 16, 2026 | 38.47 | 39.00 | 37.85 | 37.95 | 892270.0 |
| Oct 15, 2026 | 38.04 | 39.00 | 38.00 | 38.27 | 798333.0 |
| Oct 14, 2026 | 37.16 | 38.31 | 36.92 | 37.51 | 972241.0 |
| Oct 13, 2026 | 37.91 | 38.17 | 35.99 | 37.03 | 1.419M |
| Oct 12, 2026 | 38.34 | 39.89 | 37.01 | 38.23 | 1.148M |
| Oct 09, 2026 | 39.53 | 40.57 | 39.51 | 40.28 | 487164.0 |
| Oct 08, 2026 | 39.14 | 39.89 | 38.68 | 39.60 | 865033.0 |
| Oct 07, 2026 | 39.27 | 39.86 | 39.10 | 39.34 | 547001.0 |
| Oct 06, 2026 | 40.09 | 40.35 | 38.91 | 39.36 | 507277.0 |
| Oct 05, 2026 | 39.76 | 40.77 | 39.51 | 39.92 | 897920.0 |
| Oct 02, 2026 | 39.78 | 40.62 | 39.25 | 39.64 | 916733.0 |
| Oct 01, 2026 | 39.58 | 40.46 | 39.08 | 39.57 | 1.228M |
| Sep 30, 2026 | 39.30 | 39.56 | 38.72 | 39.26 | 667692.0 |
| Sep 29, 2026 | 39.87 | 40.52 | 39.15 | 39.29 | 786676.0 |
| Sep 28, 2026 | 41.29 | 41.54 | 39.54 | 40.01 | 874387.0 |
| Sep 25, 2026 | 41.37 | 41.60 | 40.89 | 41.26 | 557011.0 |
| Sep 24, 2026 | 40.63 | 41.79 | 40.00 | 41.16 | 906463.0 |
| Sep 23, 2026 | 41.61 | 42.08 | 39.72 | 40.48 | 1.081M |
| Sep 22, 2026 | 42.10 | 42.37 | 41.36 | 41.53 | 577958.0 |
| Sep 21, 2026 | 41.87 | 42.52 | 41.20 | 42.10 | 839024.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Liquidia Corp. | 42.65 |
| Pfizer Inc. | 30.03 |
| Bristol Myers Squibb Co. | 61.48 |
| Repligen Corp. | 176.93 |
| Johnson & Johnson | 263.81 |
Price Related Metrics
| PE Ratio | 11.71 |
| PS Ratio | 2.211 |
| Price to Book Value | 2.102 |
| Price to Free Cash Flow | 6.322 |
| Earnings Yield | 8.54% |
| Market Cap | 2.100B |
| Operating PE Ratio | 9.201 |
| Normalized PE Ratio | 11.71 |